DOLLIE BYRON: Open Payments
NPI 1780313346 · BRENTWOOD, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 26 payments from 8 companies in 2025. Trend: 2023 $828 · 2024 $205 · 2025 $397
Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 12 | $177 |
| Corium, LLC | 5 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| ABBVIE INC. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
| Noven Therapeutics, LLC | 1 | $14 |
Products named: FANAPT, Azstarys, CAPLYTA, REXULTI, Auvelity, VRAYLAR, COBENFY, Xelstrym.
Industry payments across TN — which companies pay providers there.
